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ABSTRACT

APPROXIMATE DYNAMIC PROGRAMMING FOR ANEMIA MANAGEMENT
Mehmet K. Muezzinog1u
Apri112, 2006
The focus of this dissertation work is the formulation and improvement of anemia
management process involving trial-and-error. A two-stage method is adopted toward this
objective. Given a medical treatment process, a discrete Markov representation is first derived as a formal translation of the treatment process to a control problem under uncertainty.
A simulative numerical solution of the control problem is then obtained on-the-fly in the
form of a contro11aw maximizing the long-term benefit at each decision stage.
Approximate dynamic programming methods are employed in the proposed solution. The motivation underlying this choice is that, in reality, some patient characteristics,
which are critical for the sake of treatment, cannot be determined through diagnosis and
remain unknown until early stages of treatment, when the patient demonstrates them upon
actions by the decision maker. A review ofthese simulative control tools, which are studied
extensively in reinforcement learning theory, is presented.
Two approximate dynamic programming tools, namely SARSA and Q-learning, are
introduced. Their performance in discovering the optimal individualized drug dosing policy is illustrated on hypothetical patients made up as fuzzy models for simulations. As an
addition to these generic reinforcement learning methods, a state abstraction scheme for the
considered application domain is also proposed. The control methods of this study, capturing the essentials of a drug delivery problem, constitutes a novel computational framework
for model-free medical treatment.

tV

Experimental evaluation ofthe dosing strategies produced by the proposed methods
against the standard policy, which is being followed actually by human experts in Kidney
Diseases Program, University of Louisville, shows the advantages for use of reinforcement
learning in the drug dosing problem in particular and in medical decision making in general.
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CHAPTER I
INTRODUCTION

Motivation
Trial-and-error is a fundamental component of reasoning. The role of this heuristic
in animal learning has been first conjectured rigorously by Edward Thorndike in (Thorndike,
1911) by the Law of Effect. His view initiated a mainstream approach in learning theory,
namely Reinforcement Learning (RL), as the prominent alternative to the Pavlovian explanation. His approach suggests that developing a strategy to cope with the environment is
possible due to two characteristic features: First, this form of learning is selective, as the
learning system selects an action among alternatives towards a goal. Second, it is associative as these alternatives are corresponded to particular situations.
Mimicking trial-and-error learning in animals constitutes a major challenge in artificial intelligence (Russell and Norvig, 2002). Due to the external information gained by an
agent, the learner, along its interactions with its environment, this form oflearning has long
been confused with supervised learning, the environment being considered as the supervisor, in artificial intelligence literature. In fact, an external supervision telling the agent what
to do explicitly barely exists. It is true that there is a signal available for the agent incurred
upon each decision, and this signal is really correlated to the agent's performance upon
each interaction. However, unlike in conventional supervised learning, it does not convey
an example for the learner. Observing such a signal gives rise to a non-trivial internal evaluation in the agent, involving learning lessons from its previous choices and reflecting this
gained experience in planning pragmatically its future. Due to this distinctive effort, mod-
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em approaches in artificial intelligence study trial-and-error learning exclusively under the
category of RL. Another computational aspect differing RL from conventional supervised
learning schemes, which have been founded on Newtonian methods and gradient descent
iterations, is that RL is applicable on dynamic and stochastic problems very effectively.
With its computational roots fed by the theory of stochastic approximation (Benveniste
et aI., 1990), RL has developed into a major research field in computational intelligence for
more than two decades (Barto et aI., 1983; Kaelbling et aI., 1996).
Formally, the process of trial-and-error is a systematic way of eliminating nonbeneficial attempts in a learning task, thus is strongly linked to the computational framework of Dynamic Programming (DP) studied in control theory (Bellman, 1957) and also
in theoretical computer science (Baase and van Gelder, 1999). However, for this powerful
methodology to be directly applicable, a critical piece of information, namely the exactlyquantified utility of each possible action at each situation that the learning system can ever
encounter, is essential (c.£ the association feature oftrial-and-error). Unfortunately, these
data become available in many real-life applications only after sufficient amount of interaction of the learning system with its environment. For example, in order to apply the
Dijkstra algorithm, a popular shortest-path solver employing DP ideas, the complete graph
information in the form of nodes and arc lengths is required in advance. In many learning
tasks, however, it is too optimistic to expect that complete information be available to the
learning system in advance. To solve the shortest path problem under such a constraint, the
learning system would have choice but to explore both the nodes and the arcs of the graph
by a number of trials, most of them leading possibly to non-optimal solutions. The information gained by exploring the graph is stored in the DP table on-the-fly, i.e. in parallel
with the solution.
The initial lack of information about the problem, which hinders or simply blocks a

direct DP solution, has given rise to Approximate Dynamic Programming (ADP) methods,
which combine the simulation-based information gathering techniques and the well-posed
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DP methods. The author's interest in the approximate dynamic programming is due to the
observation that they have been remarkably successful in overcoming real-life multistage
decision making problems under uncertainty, yet employing simple mechanisms (Connell
and Mahadevan, 1993; Tesauro, 1995; Barto et aI., 1995; Bertsekas and Tsitsiklis, 1996).
Another (and the most celebrated) characteristic of ADP is its utilizing a parametric
approximator to summarize the DP table, the only means for storing gained experience
during the entire solution process. This crucial set of information grows to unfeasibly
large sizes as the dimension of the state space is increased linearly. In particular, its size
is an exponential of the state-space dimension, a phenomenon addressed in the computer
science jargon as the curse ofdimensionality. To maintain tables cursed by dimensionality,
they are typically parameterized in ADP framework by a reasonable number of variables,
which converts the conventional DP solution from DP table updates to parameter updates at
each solution stage. As parametric universal approximators, feedforward neural networks
are primarily employed in ADP solutions for this purpose.
A majority of medical decision making instances have traditionally been based on
trial-and-error, which aims at keeping certain patient variables quantified by (possibly erroneous) measurements. The basic motive that validates the trial-and-error heuristic in this
process is the difficulty in (or in many cases simply the impossibility of) modeling the
patient. Therefore, a medical process is sometimes a model-free control task subject to uncertainty, thus cannot be handled by the classical control theory, which assumes typically a
given plant on which the control designer can rely to a certain extent.
Drug administration in chronic conditions is a typical recurrent trial and error process: A physician selects an initial drug dose based on a standard reference and observes
the patient for specific response and/or side effects. Following the observed state of the
patient, the dose is adjusted to improve the response and/or to minimize dangerous side

effects. The adjustment continues until a desired response is achieved. Here the physician
can be viewed as an agent performing goal-oriented learning.
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Scope and Contributions of This Study
This thesis work reviews ADP tools to reveal their applicability in medical treatment
processes, which involve inherently tria1-and-error heuristics. An automated procedure that
is applicable on certain treatment instances constitutes the broader objective of this study.
To achieve a valid formulation and optimal control of a given treatment process, a
two-step procedure is implemented in this work.
1. Translating a given treatment process into a Markov Decision Problem (MDP) constitutes the foremost challenge towards solution. This includes quantifying and quantizing the control variables as well as declaring internal state variables and all inputs/outputs of the considered system. Another essential task performed at this step
is the introduction of reward formulation in order to reflect the high-level control objective to rank the state transitions and underlying control actions. It is important to
discriminate this phase from conventional modeling procedures for control (Astrom
and Wittenmark, 1989), where the system dynamics need to be delineated in the form
of a legitimate state representation.
2. Having obtained a MDP formulation for the considered treatment, the second step
is selecting and customizing an ADP method to extract actions that maximize the
cumulative reward. This method operates on sample trajectories actually generated
by the patient and is assumed to have access to the patient in order to demonstrate
actions and observe their consequences. Based on these observations, the learning
system of interest ranks the states and the control actions based on their utility with
respect to the ultimate control goal. In some cases, this is even achieved in real time,
together with the actual system operation by evaluating the consequences derived
from the samples, which are generated under the control of the learning system itself.
In other words, the considered framework enables carrying out both learning and
control simultaneously. This second phase of the procedure involves particularly the
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temporal difference methods of ADP augmented by connectionist approximators,
particularly Radial Basis Function (RBF) networks that implement the control law
being developed online as a locally parameterized input-output relation.
This study views the broad field of medical treatment under a fundamental assumption, namely the process' compatibility with the MDP framework. In particular, the methods of this study are applicable on treatment processes which can be accurately accommodated in a fully-observable Markovian domain with well-defined finite sets of states and
actions. The scope of this work is limited also by fictitious patients implemented on digital
computers that are believed to be mimicking real patient behavior in the considered problems. Consequently, this study does not claim any direct contribution to real-life treatment
of any kind, although some practical concerns will be addressed in experiments, to an extent that they can be reflected in the design of virtual patients. Extensions of ADP-based
methods in medical treatment are left to succeeding studies aiming primarily a safe clinical
practice of trial-and-error heuristics.
A drug-dosing problem, namely anemia management is selected as the test bed for
the methods adopted and/or developed in this study. All experimental results reported in
this work address this problem described briefly and formulated in the following chapters.
The experimental findings are due to a joint effort maintained with the Kidney Diseases
Program, University of Louisville, which contributed to this work by providing the medical background, specifics of the benchmark problem, and continuous feedback. A particular contribution of this work, which has yet become the subject matter for (Gaweda
et aI., 2005e; Gaweda et aI., 2005b; Gaweda et aI., 2005a; Gaweda et aI., 2006a), is a
computational ground for the trial-and-error heuristics in anemia management. The author,
however, would like to stress at this point that having focused on this particular problem
should not constrain the validity of the general two-stage approach to the selected test bed.
Among other model-free control approaches in medical decision making, which are
much smaller in number as compared to model-based methods (Khoo, 1999), this study
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constitutes apparently the pioneering attempt in utilizing approximate dynamic programming for treatment purpose, although its outcomes are regarding only the virtual patients
currently.

Outline of the Dissertation
An introduction to Markov Decision Processes is made in the following chapter.
Staged decision making terminology is presented together with examples illustrating how
real-world problems are accommodated in this framework. A minimum set of conditions on
the considered problem to achieve such an accommodation are listed therein. The practical
value of this set is of utmost importance since it actually draws the crisp boundaries for the
(medical) decision problems that can be handled using the general strategy of this study.
Chapter II presents also the conventional Dynamic Programming methodology, an elegant
solver for MDP, and a discussion of its limitations. Alternative simulative sub-procedures,
which are compatible with the general DP strategy but capable of eliminating the demand
for complete information about the process, are brought to the reader's attention. The role
of parametric approximators in realizing these flexible solutions is finally explicated in
Chapter II.
Chapter III sets the test bed of this study. The problem of Anemia Management is
introduced and formulated within the MDP framework. As a critical component of anemia management, the patient response is described and possibilities of mimicking a real
patient's behavior are discussed (although the primary motivation of this work is, indeed,
avoiding the modeling process). A fuzzy patient model is advocated as a virtual patient
that can sufficiently demonstrate critical features of a real patient with reasonably simple
parameter adjustments. This model constitutes the object of the computing experiments
presented in the remainder of this document.
Chapter IV is devoted to customization the two ADP methods, namely SARSA and
Q-learning for anemia management. The performances of these approaches are evaluated
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experimentally on virtual patients with diverse response characteristics. A statistical comparison of the methods is also provided therein.
Chapter V proposes and implements a state abstraction scheme based on an inherent
feature of the valid dosing strategies for anemia patients. In particular, the monotonicity of
a valid dosing strategy with respect to patient variables is utilized to extend the reasoning
triggered by observing a state transition in the patient to other (and possibly yet unobserved)
states. This constitutes an illustration of utilizing problem-specific information in reducing
the computational demands drastically. It is shown with extensive simulations that such
an abstraction can substantially improve extraction of the optimal dosing strategy using
trials. Improvement on the performance due to incorporating the suggested mechanism to
the previous approaches is also accounted for.
Conclusions and selected future research directions motivated by this work are highlighted in Chapter VI.
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CHAPTER II
DECISION MAKING IN STAGES

This study deals with problems where decisions are made in stages. This chapter
describes a constructive framework to handle such problems, including many medical treatment instances under reasonable assumptions as formulated in the following chapters. The
considered framework stands on two legs: A Markovian setting to cast the given decision
problem - the representation, and a DP-based methodology - the solver.
In what follows, the representation is introduced together with the basic probabilistic notions. Dynamic programming methodology is then based on these notions. Some
computational limitations of conventional DP approach are highlighted and alternative procedures are introduced.

Markov Decision Problem

Finite-State Stationary Markov Chains
Markov Chains (MC) is a unique representational domain for dynamical behavior.
It adopts the elementary concept of state in system theory: the summary of the past that

acts on the future. MC representation is applicable on (time-indexed) processes, which (i)
occupy one and only one state at any given time and (ii) possess the essential Markovian
property: the necessity and sufficiency of quantifying state variables at a fixed time to in
producing their values in any future time t

> to.

An MC consists of a countable set S of states, which are usually enumerated by
positive integers: S

= {l, 2, ... , N}. Although N may be infinite, the case where it is
8

finite, i.e. the finite-state MC, is of special interest.
The key idea ofMC representation is treating the evolution of states of a dynamical process as a discrete-time! sequence of random variables {xd~o on 8, Xo being the
initial state. 2 This sequence (also called a trajectory) is assumed to be demonstrating the
Markovian property and is governed by an N x N state transition matrix P[k], where the
component

Pij [k]

denotes the probability that, given the current state is i, the following

state will be j at time instant k:
(1)
This interpretation implies clearly that P[k] is a stochastic matrix for all k:
Definition 1 A square matrix P is said to be stochastic matrix if all its elements are nonnegative and the sum of the elements on each row is equal to 1.
The final (yet the most restrictive) assumption of this study regarding MCs is that
the state transition probabilities governing all dynamics are time-invariant: P[k]

= P.

Definition 2 Afinite-state stationary Markov Chain is a Markovian process given the twotuple M = (8, P), where 8 is the finite state set and P is the stochastic matrix inducing
dynamics by providing the transition probabilities.
Note that (8, P) is an alternative to the conventional state representation, which
is praised by the classical dynamical system and control theories for providing system
analysis and design efforts with powerful tools of linear algebra and functional analysis.
In fact, the state equations of a discrete-time dynamical process, with an input sequence
specified, can always be considered as a declaration of the general term of a sequence,
1There

are also continuous-time Markov processes. The word chain is reserved here for the discrete-time

case, which is assumed throughout this study.
2 As

a note on notation, the time index k can be appended to a variable x either as a subscript

x[k], whichever is appropriate in the current context.
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Xk

or as

reducing the representation to an Me. In other words, it is always possible to switch from
a given state representation to an equivalent and unique Me. On the other hand, the reverse
direction does not always exist, i.e. it may not be possible to obtain a state representation
that governs the dynamical system exactly in the same way as a given Me. Therefore, the
generic Me representation has a broader scope than the state representation in the sense that
Me is capable of accounting for stochasticity that might be involved in state transitions in
an explicit way, by means of the state transition matrix.
The Markov chain, even with the assumptions of stationarity and finiteness standing, is not only capable of accommodating a fairly broad class of dynamical processes but
also brings novel solution techniques to the dynamical systems domain, especially when
there is no state representation available. As will be demonstrated in this study, it is even
possible to extract a partial Me representation of a stochastic system and still achieve a
certain qualitative performance measure. Moreover, these two can be performed simultaneously. These useful features ofMes are shared by conventional state representation only
in very special cases, e.g. in the case of state equations involving additive and Gaussian
nOIse.

Markovian Processes Driven by Decisions
Staged decision processes in Markovian setting form a critical class of dynamical
systems for modern engineering sciences. There are two characteristic features of these
generally stochastic processes. First, the state transitions occur due to an external effect,
called action. In particular, an action is assumed to be applied by a decision maker as an
input to the process at each transition and has a non-neglectable effect on the determination
of the next state. In a Markovian setting, the next state is produced not only by the current
state but also on the action applied. The other characteristic of staged decision processes is
that upon each state transition an immediate consequence is incurred. In real-life problems,
such a consequence is usually an immediate cost or benefit regarding the decision made on
10

Action ak-I

Reward

Reward

g(xk-l ,ak-I ,xk)

g(xk,ak,xk+l)

State

State

xk-l

xk

,---

Action ak

State

,---

xk+l

Action ak+l

Figure 1. Three stages of a decision process in Markovian setting.

the preceding state. The reward (benefit) approach is adopted in this study. An illustration
of a staged decision process including the actions and reward is given in Figure 1.
Finite-state MCs from an extended perspective provide the necessary mathematical
rigor and constitute a constructive representational domain for staged decision processes.
Two additional components to the basic MC setting are required to capture the characteristics mentioned above.
The first addition is a component addressing the actions which the target process.
This will be denoted by the finite set A augmenting M = (S, P):

(2)
which contains all possible actions that can be applied at each state. Note that, setting a
single set A for all possible states does not really restrict the actions to be applicable on
each state. In a valid decision process, it may well be the case that the decision maker faces
two different sets of options of actions Ai and Aj for two different states i, j E S. In such
cases, the global action set is determined as the union of applicable options, e.g. Ai U Aj
in this example.
The action a E A applied at state i E S can be viewed as specifying N probabilities
regarding all possible transitions originating at i. From this perspective, the role of applying
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an action for i among the elements of A is actually equivalent to picking uniquely the i-th
row ofP from m possible candidates (each adding up to unity).
Definition 3 Any function 7r(.) : 5 ---+ A mapping states to actions is called policy.

Under the finiteness assumptions above, it is easy to see that there are

151 . IAI

=

N M possible policies associated with the process.
Definition 4 A given Me M = (5, A, P) is said to be following a policy 7r if the decision

maker always performs as the action 7r( i) at state i, for all i E 5.

Note that specifying a policy to follow forces out the component A in the description
of the process in the sense that there is no need to state the set of options A, once which
option to pick is clearly stated. Specifying a particular 7r also fixes all rows of P, thus
determining uniquely all state transitions. The MC on the policy 7r is therefore denoted by

M7f = (S,P7f).
The second addition to MC to handle decision processes is the real function 9 (., ., .) :
5 x A x 5 ---+ a?, called the reward functional. The evaluation g( i, a, j) quantifies the immediate consequence of taking the action a at state i and attaining j as the next state. Note that
the considered reward formulation is compatible with the probabilistic nature of the process in the sense that taking action a at state i may result in a variety of states along which
the incurred reward may vary. Note that, when following a particular policy 7r, the reward
function can be tabulated as an N x N matrix G7f, since the reward value is dependent only
on i and j in this case: g(i, a, j) = 9 (i, 7r(i), j).
Although the considered reward formulation is fairly general, there are two implicit
assumptions underlying it: the functional g(., ., .) is deterministic and time-invariant. In
other words, the same reward is ensured in all cases whenever state j occurs upon taking
action a at state i, irrespective of the time this happens. 3 The author would like to note at
3This neither implies that state j always occurs when action a is taken at state i, nor that the action a

must be taken at state i.

12

this point that these assumptions may be dangerously restrictive in casting some real-life
problems, although they are accepted by the canonical problems handled in this study.

Problem Statement
Given a Markovian decision process M = (S, A, P, g) and an initial state i E S,
the Markov Decision Problem (MDP) is defined over the policy space and is formally stated
as follows (Puterman, 1994).

Problem 1 Find the policy 7[* which maximizes the expected discounted sum of immediate

(3)

where the sequence

Xo, Xl, ... , Xtf

is produced by the chain M1f, a E (0.1] is a specified

discount factor and the expectation is taken with respect to the probability distribution
specified by the state transition matrix P governing the Markovian decision process.
As stated formally in Problem 1, the MDP formulation seeks the optimal way of
assigning actions to states that maximizes the accumulated immediate rewards over a specified time interval. The problem is stated for an arbitrary state i E S to be taken as the
initial state of the decision process M1f. Note that, also implicit in this formulation is
the sequence of states generated by M1f as a consequence of the optimal action sequence

The kernel a of the power sequence that weights the immediate rewards is called
the discount factor. This parameter ofthe decision problem tells to what extent the rewards
due to future state transitions should contribute to the sum with respect to their distances to
the initial state in time. The meaning of a < 1 is that future rewards matter to us less than
the same costs incurred at the present time. The marginal case of a

= 1 corresponds to the

undiscounted case which sets the goal simply as maximizing the total reward accumulated
over the specified time interval.
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The problem is called an infinite-horizon MDP when t f

---t 00.

This case induces

the most general formulation. It addresses even problems with a terminal state, i.e. a goal
state which finalizes the state transitions. In fact, such problems with a = 1 are called the

(stochastic) shortest path problems. Analysis of these problems, which is skipped in this
study, provides an foundation of the other types of problems accommodated by the infinitehorizon formulation. The author recommends the text (Bertsekas, 2000) for an insightful
treatment of this topic.
The focus of this study will be on the discounted (a
with a bounded reward function, i.e. g(., " .) ::; !vI

<

In this case, the decreasing geo-

00.

metric profile {a k M} makes J7r (i) well-defined for all

7r

< 1) infinite horizon problems

and i, thus a solution to Problem

1 always exists in this case. These problems constitute the second level of generality in the

classification ofMDPs and their solution methods are outlined in the following section.
The remaining two classes of MDPs are classified by the cases where there is no
terminal state, a

=

1, and/or the reward g(',',') is unbounded. These types of problems

are out of the scope of this study.

Dynamic Programming
Dynamic Programming (DP) is a methodology to solve MDPs. It was manifested in
(Bellman, 1957) as a numerical solver. The presentation begins with a case study analyzing
a discrete-time but continuous-state optimal control problem, namely inventory control. Although the problem utilizes the common state representation, the material then extends the
discussion and the algorithm's application field to general Markovian representations. Due
to the mathematical rigor and the generality of the perspective achieved by Bellman in his
text, DP is among the few engineering tools whose computational benefits and limitations
have been known almost completely since their conception.
The application field of DP, on the other hand, has grown enormously in the last
five decades. Modem approaches to DP are no longer confined to the classical control
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theory arguments, but rather evaluate it as a general class of heuristics that minimize nonbeneficial attempts in the solution of a staged decision problem, thus saving resources and
time. Along its 50 years of history, numerous problems have been formulated and solved
within this framework. There is a significant diversity among real-life engineering problems, especially in the broad field of operations research, where the only reasonable solutions can be obtained by DP-based methods.
It can be argued from an algorithmic point of view that DP methods balance the

computational burden and the memory requirement in the solution of a problem in an alternative way: DP provides generally a faster exact solution in contrast to other known
heuristics, such as classical depth-first or breadth-first search strategies, at the expense of a
larger amount of (dynamic) memory that also needs to be maintained. A typical example
that demonstrates DP characteristics is the well-known Dijkstra algorithm (Baase and van
Gelder, 1999), which computes shortest paths in a given graph. Along with its algorithmic
aspect, there is a variety of interpretations ofDP and a voluminous literature on the analysis
and synthesis of its methods.
The key element of a DP-based solution procedure is the DP table, which contains
values ofthe states already visited in the search space. A value is the unique measure of the
benefit in including the associated state in the optimal trajectory, which would be generated
by the optimal policy (i.e. the solution of MDP). The term dynamic refers to the updates
on the DP table and the time-varying (usually growing) memory requirements to maintain
this table along the solution, as the procedure explores all elements of the state space and
ascertain their values.
The formal definition of value has already been made implicitly in the MDP formulation in (3):
Definition 5 The value of state i in a Me following the policy
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7r

is evaluated by the value

function pr ( .) : S

---t

~R

J(i)

defined by

~ E { ~ a k . 9 (X" 1l'(Xk), Xk+1)

Xo =

i} .

(4)

Detennining the value function is a critical sub-goal in the DP strategy. Once the value
function is known for each

7f,

the remainder of the solution turns out to be picking merely

the policy 7f* which maximizes J7r( i) evaluated attheprovided initial statei: arg maxp { JP( i) :

P E II}, where II is the (finite) set of all possible policies. Therefore, in many applications,
DP is viewed only as a method for detennining the value function only, although value
iteration is only a part of its role in staged decision making.

Principle of Optimality
All DP strategies are based on the principle of optimality:

Definition 6 Let
7f*,

7f*

be an optimal policy for the MDP in (3) and assume that when using

a given state i E S occurs at time t

truncated version initiated at k

> 0 with positive probability. Consider the

= t:
(5)

Then, the principal of optimality holds if and only if the policy 7f* is still an optimal policy
for the truncated problem for all 1 ::; t ::; t f.
The notion of this principle is intuitively very sound. Humans apply this principle routinely
in making daily-life inferences such as:

Since 1-64 is the shortest route from Louisville to Lexington and since this route passes
through Fran~rort, then 1-64 is also the shortest route between Franlifort and Lexington.
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The Dynamic Programming Algorithm
Using the definition (4) of pro directly, one obtains

J7r(i)

=

E

{f

a k . 9 (Xk' 1T(Xk), xk+d

Xo

=

k=O

E {g("O, 7[(XO), Xl)

t

i}

+ ~ a k . 9 (Xk, 7[(Xk)' .T'+l)

p;; [g( i, 7[(i), j) + E {

t,

Xo =

"k . 9 (x,. ,,(X,), X'+1)

i}

Xl

=

j}

1

N

LPij [g(i, 1T(i),j) + aJ 7r (j)] ,

(6)

j=l

which relates the values of two consecutive states i and j in a given process. An immediate
result that can be derived from (6) is that, if the values of all possible successors of a state i
is known (or guessed), then the value of i can be exactly computed. Of course, the transition
probabilities Pij are critical in this calculation and they are yet assumed to be known in the
reasomng.
Application of the principle of optimality on (6) then yields the crucial property of
the optimal value function, namely J7r* (.) is a solution of N linear equalities involving N
unknowns:
N

J7r* (i) =

L [Pijg( i, 1T(i), j) + aJ7r* (j) ] '

i E S

= {1, ... , N}

(7)

j=l

called Bellman's equation. By adopting the matrix forms P and G for the transition probabilities and the reward function, respectively, they can be written in the compact form

J7r* (1)

,r* (1)
J7r* (2)
= diag (PG

T

J7r* (2)
)

+ aP

(8)

J7r* (N)

J7r* (N)

where diag(·) functional gives the diagonal of its argument as a column vector.
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The transition probabilities P driving the process and the rewards G are critical in
this calculation. Once they are known, the solution to the evaluation problem is obtained
by

And once the states are evaluated in this optimal way, the solution to the MDP is extracted
by
n* (i)

+-

{a E A : a maximizes the probability Pw}

where j' is the index of maximum element of [ J"' (1) Jrr' (2) ...

J"' (N)

r.

(10)

The

resulting policy n* is clearly the desired one as it maximizes the chance of switching to the
most beneficial state, maximizing the cumulative reward (3).
There is a variety ofDP algorithms, each leading to the solution (9) iteratively. Their
common approach is starting by the initial guesses of state values and a particular initial
policy. This corresponds to initializing the DP table by these guesses, possibly randomly.
The adopted initial policy may also be random, or a best-guess one based on the prior
information on the considered problem.
The solution procedure is a loop containing the two particular sub-procedures:

a.

Value Iteration The following two steps constitute the value iteration sub-

procedure ofDP.
1. Apply the policy in effect and observe the next state and the incurred reward.
2. Using the relation (6) between the values of new and previous states, the value ofthe
new state in the DP table is updated assuming that the value of the preceding state
was correct.
Note that, in the light of the discussion above, performing these steps sufficiently many
times on a fixed policy n is equivalent to numerically solving (6) for the exact values J7r (.).
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h.

Policy Iteration Note that any update on the DP table may result in an in-

consistency between the current status of the DP table and the policy that is being applied,
and the value iteration is no exception. In other words, the policy in effect may no longer
yield the most beneficial states with respect to the current values after performing the two
steps above for any number of times.
To achieve consistency between the policy in effect and the current content of the
DP table, a policy iteration step is essential. This is achieved simply by applying (10) for
k

each state, where, instead of pr> , one has now the current values J7r represented in the DP
table:
1[k+l

(i)

t----

{a E A : a maximizes the probability Pij> }

(11)

where j* is the index of maximum element ofthe current DP table.
The point where DP algorithms differ is actually the point where they perform the
policy iteration step. The Gauss-Seidel iteration (Bertsekas and Tsitsiklis, 1996) for instance performs policy update upon each value iteration step (i.e. right after Steps 2 above).
Extracting the policy from the current DP table may alternatively be performed after a certain amount of repeating steps 1 and 2 within a loop. A third scheme may be iterating the
policy upon encountering all states.
This interaction between the policy in effect and the values in the DP table continues
until both of them convergence. Under mild assumptions, including a

< 1, all such proce-

dures can be shown to be really converging along iterations to a policy which is consistent
with the limit values in DP table, where the limit policy is the optimal policy:

k

1[k -+

1[*

as

-+ 00.

The general DP strategy outlined here constitutes the basis of the approximate methods, which will be utilized for the problems ofthe following chapters.
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Limitations
Despite theoretical guarantees on their convergence to an optimal policy, the computational demands of DP solutions may be overwhelming. The obvious reason for this
is that a DP algorithm handles the states individually and builds relations between their
values. As a result, the number N of states is a direct parameter of the computational load:

N real numbers in the DP table to be maintained, each requiring N(N - 1) additions (c.f
(6)) in the value iteration step. This is, by itself, a heavy burden for a DP algorithm and
is especially a major problem when dealing with problems with continuous state-spaces,
such as the ones of interest to us in this study. Such problems require a preprocessing
which quantizes their states into a finite state space in order for DP methods be applicable.
The density of this finite space is usually proportional to the accuracy of the approximate
representation. This means that for accurate results by DP, more and more states should be
augmented, which in tum may load the solution algorithm with unacceptably many computations.
Taking into account that the dimension of the state space is a logarithmic function
of the number of states, linear growth in the dimension gives rise to exponential increase
in the space requirements of any DP algorithm. This effect has been first named by Bellman as the curse of dimensionality. It constitutes the most serious obstacle for application
DP methods; because many real-life decision problems can only be modeled on larger dimensional state-spaces than any available processor can accommodate to perform a DP
solution in reasonable amount of time. It should be noted that the drastic improvement
on processor speeds in the last few decades made accommodating many problems within
this framework possible (Powell, 2005). Although the borders of the application field of
DP algorithms seem to be drawn by the technology from this point of view, a certain technological level that would infallibly overcome the curse of dimensionality can never be
gIVen.
The second major problem of DP methods is that the process must be modeled by
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exact state transition probabilities. That is knowing the process model exactly is essential
to carry out a conventional DP solution. With any amount of inaccuracy in representing these parameters, one can no longer guarantee the optimality of the resulting policy.
Needless to say, the lack of information on some or all of these parameters is absolutely
intolerable since the algorithm requires their explicit values in the value iteration step. As
a result, conventional DP methods are certainly classified as model-based methods, which
contradict with the point of view to the medical decision problems in this study.
These two issues, common to all DP solutions, can only be resolved by replacing
two fundamental sub-procedures, namely value and policy iteration, by their approximate
versions. As in any approximation, the benefits of this substitution corne at the expense of
settling with a sub-optimal policy instead of the exact solution 7r*, which would really be
ensured by the conventional DP solution.

Approximate Dynamic Programming
The role of approximate DP methods in solving MDP is interpreted as twofold in
this study, as previously mentioned and described in the remainder of this chapter. Therefore the treatment of ADP in this study is broader than the views that consider ADP solely
as a method of parameterizing the DP table to overcome the scaling problem. Though
addressed rigorously in the following sections, such a parameterization constitutes a secondary goal for us that will even be disregarded in some of the demonstrations on the
following chapters.
Instead, the focus here is mostly on addressing the problem of unknown (or partially
known) transition probabilities here. This is viewed as the primary shortcoming of conventional DP methods, because obtaining the patient behavior (i.e. the process model) in a
medical treatment may be too costly from many aspects. The medical decision maker thus
faces the difficulty of extracting the process model (i.e. how the patient responds to medical decisions) simultaneously with achieving the therapeutic goal. He/she does not usually
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have a patient model to begin the control directly, and without a model conventional DP
methods are simply inapplicable. This is a typical chicken and egg problem.
As will be shown shortly, a solution to this dilemma brings another form of approximation scheme into the big picture of staged decision making. It deserves an analysis still
under the ADP topic, although this new approximator serves for another purpose than the
standard view to ADP suggests.

Coping with Model Uncertainty within MDP
Making decisions on a MC with unknown transition probabilities and rewards is
troublesome but common matter in critical tasks, including medical treatment processes.
Moreover, in many of these instances, one has no access to the process (c.f. the black box
phenomenon), which renders the simulation as the only method to gain information on the
dynamics. In particular, the system must be probed by a set of inputs at certain states and
the parameters of the dynamics must be determined based on the observed outcomes from
the black box, i.e. state transitions. The goal here is to explore the system.
Reaching the optimal policy, on the other hand, is a serious control task, and a constant improvement in the state values, as guaranteed by the conventional DP algorithms,
must be exploited to solve the problem. Since the two goals conflict in general, a standard
approach in handling unknown (or partially known) processes is to isolate exploration from
exploitation (Barto et aI., 1995).4 The former, also called the modeling process, is independent of the upcoming control efforts, and the sole objective is to represent the dynamics
as accurate as possible. The latter comes in effect strictly after the modeling is over (or
suspended) and during its operation, the obtained model on the preceding step is assumed
to be perfectly accurate (i.e. certainty equivalence principle).
In some most critical instances, however, there is no time to perform exploration and
4This trade-off has deep roots in control theory. It is a fundamental problem of adaptive control (Astrom
and Wittenmark, 1989; Kumar, 1985).
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exploitation separately, thus it is further necessary to combine the two (usually conflicting)
efforts. Again, most medical decisions are subject to this requirement, due to limitations
on treatment time.
Simulative approximate dynamic programming methods combine simulative modeling (i.e. learning the model) with the continuous tendency to encountering advantageous
states towards the objective (i.e. MDP solution). These methods include various forms of
reinforcement learning (Sutton, 1988) that will shelter also the methods utilized/developed
in the sequel. The unique feature utilized in these methods is their ability to maintain both
goals simultaneously and reasonably accurately.
The viewpoint adopted in this study is augmented by computational intelligence
components. The focus is specifically on the design and analysis of learning systems that
maintain a particular DP method to solve such a decision problem, given only sequences of
data generated by the dynamic process. Since the dynamical form governing the process is
disregarded in this setting, the objective could be classified as a model.Jree control task.
The basic strategy common to the methods of interest here is to make use of the
information gain obtained by the state transition i
9 (i, n( i),

----+

j and the corresponding reward

j) in updating the values in the DP table. In fact, such an observation contains a

novelty as an aid in coping with the two unknowns, i.e. the value J( i) and the transition
probability Pij'

Method of Temporal Differences
Being an alternative to the value iteration step of conventional DP algorithms, Temporal Difference (TD) methods, parameterized by A E [0, 1] is an iterative way to calculate
the state values under a specified policy in effect (Sutton, 1988).
TD iterations are applied on a sample trajectory generated by the actual process,
whose transition probabilities are typically unknown. TD(A) is an episodic (approximate)
value iteration process in the sense that the TD iteration is repeated within a loop, for each
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state transition observed in the sample trajectory. When the sample trajectory is finished,
the stage is left for a policy iteration procedure, where the policy in effect is improved by
examining the resulting value function, which was prepared by the last TD iteration step.
The learning proceeds with a new trajectory generated by the new policy.
A single iteration ofTD performs partial correction on the current state values based
on a comparison between the immediate reward observed and the values of the last and the
current state. Note that these three quantities are strictly linked to each other by (6).
In the basic case of A = 0, a backup toward the correction is performed by

where 0['] is a positive learning rate sequence. Using a well-known result from the stochastic approximation theory (Poljak and Tsypkin, 1973), o[k] is selected in this iteration (and
in almost all variants of TD) as a diminishing step-size satistying limk-->oo o[k]

2::;::00[k] <

-t

°

and

00.

For A > 0, the immediate correction is propagated towards the values of future
states, which will be examined later in the sample trajectory:
1-1

.r(Xk)

+-

J7r(Xk)

+ o[k]

L Ak- m (g(Xm, 7f(Xm) , Xm+l) + a.r(xm+d -

J(Xm)) , (13)

m=k
where 1 is the episode length. The rationale behind introducing this propagation is that the
values of the future states will effective in the current state's value due to the basic relation
(6).
Validated by the convergence results (Sutton, 1988; Jaakkola et al., 1994), tabular
TD methods constitute one of the most efficient ways of learning from trajectories. On the
other hand, TD is a stochastic process that is biased on the selected samples, so the method
may not be fast enough in deciding on the optimal policy to be applied in many critical
applications.
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Value Function Approximation
For a parametric approximator ¢(., r) utilized to represent the state values, TD()')
iteration can be converted to the update rule of the parameter vector r as
/-1

r[k

+ 1]

=

r[k]

+ 6[k]V'¢(Xb r[k]) L

).k-m (g(Xb 7r(x~;), Xk+l)

m=O

which is actually an incremental gradient update of r based upon the observation of

g(;r;b 7r(Xk), xk+d (Bertsekas and Tsitsiklis, 1996).
The convergence of the last iteration has not been established for all approximation
models, i.e. for all forms of ¢( ., r). In fact, it has been shown in (Tsitsiklis and van Roy,
1997) that it diverges for a particular closed-form nonlinear model. Available constructive
results (Dayan, 1992; Bradtke and Barto, 1996; de Farias and van Roy, 2000; Boyan, 2002;
Bertsekas et al., 2004) on the performance of TD with value function approximation are
currently limited to the basic case of linear approximation of J (.).
The primary benefit of value function approximation is the reduced computational
demand of maintaining a parameter set compared to the tabular TD. In fact, parametric approximation appears to be the unique opportunity to cope with the curse of dimensionality,
the serious thread on applicability of tabular DP methods, as mentioned above.
Although the nature of TD does not allow for eliminating completely the adaptive
nature of the procedure on the presented trajectory (as this data constitutes the sole information that needs to be presented sequentially to the method), it is indeed possible to reduce
the expected time for the procedure to finalize the parameter updates on the approximation
scheme (Bertsekas et al., 2004). Unlike the tabular methods, several state values are affected by the parameter update performed based on a single state transition. This should be
viewed as a side-benefit of dynamically approximating the value function.
Value function approximation is the most popular way of incorporating connectionist schemes into this learning task. An approximation scheme employing an RBF network
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is suggested in the Chapter IV on a case study.

Policy Approximation
Another point where parametric approximation could aid ADP methods is the policy representation. In the original ADP setting, the policy is maintained in the form of
a explicit lookup table relating states to the control actions. It should be noted that there
are other approaches which take the concept of policy in different ways, such as probability
distribution of actions given each state (Sutton and Barto, 1998). However, in any case, this
table identifies an algebraic relation, which could really be implemented as an input-output
relation of a parametric approximator.
Although such an approximator has nothing to do with the curse of dimensionality,
there are still two important reasons to employ it: First, as in the case of value function
approximation, the computational burden of updating a tabular policy (by policy iteration
methods) grows exponentially with the dimension and cardinality of the state space. Second, the discrete nature of MDP results in a policy which is valid only on discrete points
(states), and there may be a practical necessity to extend the policy to a continuum sampled
by these points. In the latter case, the role of the connectionist tool integrated in the learning process goes beyond just approximation and turns out to be an interpolator of a general
continuous control law as illustrated in Figure 2.
RBF networks have been proven to be effective tools for generalizing the control
law (Sanner and Slotine, 1992). An RBF-based policy approximator is proposed also in
Chapter IV.

Control-Oriented Variants
DP table is a novel and very useful tool, which is processed based on observations
of the actual system behavior and then used indirectly to develop a control strategy. As
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Discrete Policy
(obtained by ADP)

~

"Continuous
Policy
State Space

Figure 2. Policy interpolation.

mentioned in the MDP definition, correct evaluation of states according to (1) is equivalent
to solving the problem. Having obtained the values of the states, it is straightforward to pick
actions that yield the most advantageous states, constructing an optimal policy. However,
even after correct evaluation, the trivial maximization of the state values over the control
actions may be costly, especially when there are too many alternative actions to take.
At the cost of populating the DP table, it is possible to simplify this final maximization stage by evaluating each state-action pair, instead of leaving the effect of actions on
the state values implicit in the state values, as done in (1). With this extension the DP table
becomes a 2D array with entries pointing to the value of state-action pairs:

Q(s,a)

~ E [f(lg(Xk,ak,Xk+l)

Xo = s,ao = a].

(15)

k=O

The Q-values are then updated according to generalized versions of TD methods,
called Q-Iearning methods. In particular, the generalized version of TD(A) (c.f. (5)) to
maintain the new DP table is given by
I-I

Q(Sk' ak)

+-

Q(Sk, ak)+5[k]

L Ak- m (g(Sm' am, Sm+l) + aQ(Sm+l' am+l) m=k

Q(Sm, am)),
(16)
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l being the episode length. The convergence of this iteration to real Q-values is established
in (Watkins and Dayan, 1992; Tsitsiklis, 1994) under mild statistical assumptions.
Using Q-values instead of J's trivializes the policy iteration step as the best action
for a state s is the index of the maximum element of the row indexed by s, which is evident
in the Q-table. Since control actions are addressed explicitly in this formulation, Q value
representation is in general preferable when dealing with control problems. To cope with
medical decision problems, which are considered as control problems in this study, this
particular view is adopted and the considered ADP methods are picked among Q-learning
methods and their variations. The discussion made in the preceding section on approximation is still valid in this new learning scheme.
A critical issue in the choice of the suitable ADP tool is to decide whether to learn
on-policy or off-policy. Off-policy methods enable learning by observing the effects of a
policy other than the one processed, so that probing the process (i.e. the patient in medical
problems) with inadequate policies may be avoided. This feature makes off-policy methods
appropriate tools for medical applications considered in this study. On the other hand, onpolicy methods are mathematically tractable and, hence, attract the majority of the research
efforts in AD P.
As a final note, the TD and Q-Iearning iterations presented above constitute a general framework of many simulation-based control methods and is dependent only on the
observed state transition and the resulting reward. Therefore, they do not actually point to
a specific type of the learning method in the above terms. What categorizes a simulative
ADP method as an on- or off-policy is the source of the policy being applied to generate
sample trajectory, which is then processed by TD or Q-leaming iterations.
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CHAPTER III
ANEMIA MANAGEMENT PROBLEM

In this chapter, the problem of anemia management in patients with End-Stage Renal Disease (ESRD) is introduced as the test problem on which the methods of this study
will be demonstrated.
Anemia due to End Stage Renal Disease (ESRD) is a common chronic condition
in patients receiving hemodialysis (Eschbach and Adamson, 1985). The reason is known
as the insufficiency of a hormone called erythropoietin (EPO), which stimulates the production of red blood cells (erythropoiesis). In fact, the hemoglobin (HGB) is the building
block of these cells and its derivation in blood known to be correlated with that of EPO.
The preferred treatment of renal anemia consists of external administration of recombinant
human erythropoietin (rHuEPO, or EPO). Treatment process aims at maintaining the HgB
level between 11 and 12 gldL. This problem is formulated in the sequel as a MDP with
unknown transition probabilities.

Individualization of Chronic Pharmacotherapy
Drug administration in chronic conditions is a recurrent trial and error process. Typically, a physician selects an initial drug dose based on a standard reference and observes
the patient for specific response and/or side effects. Following the observed state of the
patient, the dose is adjusted to improve the response and/or to minimize dangerous side
effects. The adjustment continues until a desired response is achieved. Therefore, the
physician can be viewed as an agent performing goal-oriented learning.
Oftentimes, the relationship between the drug dose and the patient's response is
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complex. Practitioners attempt to use protocols and algorithms to simplify this relationship.
However, protocols and algorithms are developed from average responses to treatment in
populations of patients. Individualization of drug dosing is complicated by the patient's
response to the drug and to other concurrent medications.
The application of DP methods in pharmacotherapy has been advocated by Bellman (Bellman, 1983). A pioneering example for drug delivery optimization can be found
in (Buell et aI., 1970). Other examples include the works of Hu et aI. (Hu et aI., I 994b; Hu
et aI., I 994a). Very recently, Shaeffer et al. (Schaeffer et aI., 2004) provided a review of
modeling medical treatments using MDP. Moore et aI. (Moore et aI., 2004) demonstrated
a successful application of the Q-Iearning algorithm to closed-loop control of patient sedation in an intensive care unit.
Anemia is an almost universal sequel in an ESRD patient. Until the introduction
of recombinant human EPa, ESRD patients faced severe cardiovascular risk factors due
to multiple transfusions. However, the use of EPa creates additional challenges to the
physician. The National Kidney Foundation's Dialysis Outcomes Quality Initiative recommends maintaining HGB levels within a narrow range of 11 - 12 gldL. To achieve this,
protocol-based strategies exist for EPO administration.
Based on the population response, these strategies adjust the dose amount or the
dosing frequency based on the HGB level. The dosing of EPO is labor intensive and requires trained personnel to assess monthly HGB and iron levels and to make adjustments
or assessments every two or four weeks. Having computational tools support the medical
personnel in this difficult task would be a major step forward.

Problem Statement
The problem of anemia management for a given patient is a typical staged decision
problem under uncertainty. The quantity to be kept under control is the HGB, whereas the
control input is the amount of EPa administered by the physician. The iron stores in the
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patient, determined by Transferrin Saturation (TSAT), have an impact on the process of
red blood cell creation and are considered as a state component together with HGB. In this
setting, the patient is viewed as a discrete-time dynamic system with the state space 1i x S,
where 1i and S are sets of valid HGB and TSAT levels, respectively. The control space,
i.e. the set of valid EPO amounts, is denoted by E. As the measurements are performed
monthly, the time index k in the state representation denotes the months.

Patient Model
In the classical pharmacological framework, a patient's response is analyzed using a

PKlPD compartment model containing a set of differential equations. In the case of the red
blood cell production, called erythropoiesis, regular measurement of EPO concentration
would be required to acquire all the information necessary to build a PKlPD model. Due
to the high cost of this procedure, alternative modeling methods, such as Artificial Neural
Networks (Zurada, 1992), become a feasible option. In (Gaweda et aI., 2003), a populationbased neural network was proposed for dose-response modeling in anemia management.
For the purpose resembling a patient in generating simulated trajectories, a subpopulation approach (Brier et aI., 2006) is used to make up a patient. The underlying
principle for this approach is the existence of several characteristic response groups within
a patient population. Each one of these groups is assumed to bear a unique dose-response
relationship. Using fuzzy rules, a patient's response is first classified and subsequently
a one-step-ahead prediction of HGB level is obtained using the following second-order
model:

xdk + 1]

Bla[k - 1] + B2a[k]

+ B3a[k + 1] +

B4XI [k - 1] + B5XI [k]
where a is the control input (EPO),

Xl

+ B6X2 [k] + Bo

is the HGB, and

:1;2

(17)

is the TSAr. The response is

classified based on the six month average levels of HGB, TSAT, and EPO. The proposed
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approach can be conveniently implemented using Takagi-Sugeno (TS) fuzzy model (Takagi
and Sugeno, 1985).
Records of 186 patients at the Division of Nephrology, University of Louisville,
were used in this study to perform data-driven estimation of the TS model. The data were
randomly divided into equally sized estimation (training) and evaluation (testing) sets, containing data of 93 patients each. For consistency, a total of 100 model estimations were
performed using different patient selections for estimation and evaluation. Eventually, the
following three-rule TS model was obtained:
R1

:

If (avg EP06m, target HGB 6m , norm TSAT6m)

Then HGB[k + 1] = 8 1 (
R2

:

If (avg EP06m, target HGB 6m , low TSAT6m)

Then HGB[k + 1] = 8 2 (
R3: If (high EP06m, low HGB6m, low TSAT 6m )
Then HGB[k + 1] = 83 (
In these rules, the subscript 6m denotes the six month average of the corresponding quantity, 8 i are the parameter vectors of the predictive model (17), and (is the regressor vector:

( = [EPO[k - 1], EPO[k], EPO[k + 1],
HGB[k - 1], HGB[k], TSAT[k], 1]
Two rules (Rl' R2 ) specifY the HGB response for normal responders, i.e. the patients who achieve target HGB levels upon administration of average EPO amount (ca.
12, 000 Units per week). These two rules cover normal responders with low and normal
TSAT, respectively. The third rule (R3) specifies the HGB response function for a group of
patient, called poor responders. These are patients who receive high amounts of EPO yet
their HGB level stays low. The reason for using fuzzy sets to represent the response groups
is due to the fact that patients in real life exhibit features typical for both groups to a certain
degree. In other words, only very few patients can be classified strictly as a normal or poor
responder.
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The state variable
around the mean

:1:2

X2

is assumed to be a random variable with normal distribution

and variance

17fSAT'

The random variation of TSAT emulates the

uncertainty in the process dynamics. The main control objective is to drive the HGB level
to and maintain within the target range 11 - 12 gldL. For simplicity, it is assumed that
maintaining HGB within target range is equivalent to keeping it as close as possible to the
median, i.e. 11.5 g/dL.
The author would like to emphasize at this point that the sole purpose of the patient model specified above is to generate realistic sequences of trajectory. In the learning
scheme described below, the qualitative properties of this model are never taken into account by the learning system, which actually assumes that it has access to a real patient
from its own perspective.

MDP Setting
The state space ofthe considered MDP is first reduced to 28 representative states by
quantizing the HGB and TSAT intervals with medians fixed at 1i
13, 15} and S
defined as £

= {5, 10, 11, 11.5, 12.33,

= {10, 25, 40, 70}. The admissible set of discrete actions for each state is

= {O, 5,10, ... , 60}. There is a number of alternatives on the choice of the

reward function as defined next.
Having decided on the state and the action spaces, the second step in the formulation
stage is to reflect the control objective, i.e. stabilization of Xl at 11.5. The designer is
absolutely free in choosing any reward formulation as long as it is consistent with the
specified goal. This study considers two reward functions associated to the state transition

x[k]

~

x[k + 1].
The first one is chosen merely as the negative of absolute difference in the first state

variable from the target level:
gl

(x[k], x[k + 1]) = -Ixdk + 1]- 11.51·
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(18)

The second reward formulation is a finite-valued function defined by
-1 , 11.5 ~
V

xdk] > xdk + 1]

xdk + 1] > xdk]

~ 11.5

0.5 , xdk + 1] > 11.5> xdk]

(19)

V xdk] > 11.5 > .Tdk + 1]

1

o

, xdk + 1] = 11.5
otherwise

Although the general ADP framework permits, these choices does not include the action
value ark] as a parameter of the reward. s
The task of drug dosing as an MDM is then posed as follows: For all possible initial
conditions x[O] E 1t x S, determine the best control (action) a[O] such that the expected
cumulative discounted reward

Q (xIOI, ala])
is maximized, where 0

~ E [~'i9 (xlk], xlk + 1])

alOI]

(20)

< a < 1 is the discount factor.

50m itting the drug dose from reward formulation implies that the resulting learning mechanism will not
demonstrate any tendency of minimizing the drug dose, although this tendency may be obvious in real clinical
practice.
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CHAPTER IV
LEARNING THE DOSING POLICY

Reinforcement Learning (RL) is a computational framework under ADP that mimics the goal-oriented knowledge and skill acquisition in humans and animals. Within this
framework, an agent interacts with its environment by performing actions and observing
the states. Based on the state transitions, each action is rewarded or penalized, conveying a
critic to the agent on the immediate benefit of its preceding decision. Approaching the drug
delivery problem from this point of view, the physician can be viewed as the agent, drug
dose - as the action, patient - as the environment, and patient's response - as the state. Several authors have advocated the use of techniques underlying the RL to medical decision
making (Bellman, 1983), (Hu et aI., 1994b), (Hu et aI., 1994a) over the years. However,
applications of RL to drug administration have surfaced in the literature only very recently
(Moore et aI., 2004).
This chapter presents two conventional RL applied on the drug-dosing problem
in order to extract the optimal dosing policy for individuals without any specified doseresponse model. In the first approach, beginning with a common-sense policy, the patient
is simulated along episodes, each demonstrating the policy in effect on the unknown patient
model. The current policy is improved by using the gained experience at the end of each
simulation episode. This is a training-oriented approach which emphasizes exploration.
The second approach presented here is an application of the conventional Q-Ieaming strategy (Watkins and Dayan, ] 992) on anemia management, which explores and controls concurrently. Here, the policy improvements occur at each state transition, so the policy is
continuously changing. Therefore, there is no particular policy in effect that is being fully
demonstrated on the patient. It is shown that, when there is a time constraint on the treat-
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ment process, which is naturally the case in clinical practice, the latter method performs
as well as the Anemia Management Protocol, the standard dosing procedure of Kidney
Diseases Program, University of Louisville.

Episodic On-Policy Learning of Dosing Policy
The first attack toward the problem has adopted episodic and on-policy interpretation of the drug-dosing process, where a learning episode includes a trajectory simulated
with a random initial state and by using a particular policy. Here gaining experience on
the model (by examining the state transitions) and improving the policy (by TD iterations)
are separate and sequential subtasks in a loop. In particular, the SARSA(A) algorithm, an
episodic on-policy ADP process, is employed here to develop a drug dosing policy for an
individual patient. In this setting, the learning occurs by reflecting the experience gained
within an episode to improve the policy in effect. Such a learning scheme offers a better
monitoring of the improvement in policy along the proposed approach.

SARSA Algorithm
The learning progresses along the episode by evaluating each transition observed
within the episode, the incurred immediate reward, and then by correcting the Q values of
these transitions. In particular, it can be shown that the quantity

6[k]

=

gl(x[k], x[k + 1]) + ,Q(x[k + 1], ark + 1]) - Q(x[k], ark])

associated to the state transition x[k]

---->

(21)

x[k + 1] due to the action ark] is a correction on

the estimate Q(x[k], ark]) of the state/action pair (x[k], ark]). For each transition x[k]-t

x[k + 1] encountered in an episode due to ark], the SARSA(A) algorithm performs the
update

Q(x[k], ark])

~

Q(x[k], ark])

36

+ v6(1 + e(x[k], ark])),

(22)

where v is a sufficiently smallieaming rate and e(x[k], ark]) ;::: 0 denotes the eligibility of
the state/action pair (x[k], ark]) in this correction. After this correction, before proceeding
with the next transition, eligibility of the current state/action pair is first updated as

e(x[k], ark])

~ 1 + e(x[k],

ark])

(23)

and then the entire e table is iterated as
e

~

v)..e,

(24)

where)" E [0,1] is a parameter of the algorithm (c.f. (13)). When).. is small the state/action
pairs looses rapidly their eligibilities to update the Q entries. So the frequency of encountering a particular state/action pair in the trajectory becomes a less important effect in the
update of the associated Q entry. For).. = 1, all encountered state/action pairs are treated
equi-eligible in the update of Q table. Note that the introduction of e provides an efficient
implementation of the summation appearing in the original temporal difference definition

(13).
After the Q and e updates for each state transition observed in the sample trajectory,
the final step performed by the algorithm to complete the episode is the update ofthe policy
based on the resulting Q table:

p (x) = arg max Q (x, a) .

(25)

aE£

This particular policy determined merely as the maximum element of Q is called the greedy
policy.
In order to apply SARSA()") on the drug dosing problem, the initial trajectory (of
the first episode) oflength 24 is generated using the linear model (17), where p is computed
using the first six measurements from the considered patient. The corresponding reward sequence is then obtained by evaluating the reward function for each state transition observed
in the generated trajectory. Note that there are 28 states and 13 possible actions for each
state, so the Q-table has 364 entries.
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Sample Trajectory

9 ( ik' ik+ 1 ) = IHGB[k+ 1] - 11.51

Update
Q-table

k=k+1
No

Learning
the control

I
Learning
the values
of actions

/Iaw

State/action
Values
Q*

Update
Policy

New Learning
Episode

Figure 3. Proposed episodic anemia management scheme employing SARSA.

For diminishing learning constant v and A E [0, 1], the iteration on the policy performed at the end of the episodes based on the generated Q-table converges to an optimal
policy, where the algorithm terminates, provided that all state/action pairs are visited frequently enough (Sutton and Barto, 1998).
The block diagram of the learning scheme proposed in this section is illustrated in
Figure 3.

Approximating Q-table using RBF Network
Storing and updating the values of all possible state/action pairs explicitly in the
Q-table necessitate exponentially larger amounts of memory and computation power as the
cardinality of the state space expands. In such cases, a compact parametric representation
of the Q values in the drug dosing problem turns out to be essential. Note that, the required
approximation would not be in the traditional fonn of interpolating a finite set of static
data, but rather constitute a representation that adapts itself incrementally to the updates
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performed by the ADP procedure upon each state transition.
Approximating the dynamic programming table using artificial neural networks has
been proven to be an effective way of handling large decision making problems (Bertsekas
and Tsitsiklis, 1996). Although it is computationally feasible to maintain explicitly the Q
array in this problem setting with 364 entries in the setting above, in order to shed light onto
the expanded versions of the considered problem, a connectionist approximation scheme is
incorporated with the original SARSA method.
An RBF-based approximation scheme is considered here, because such algebraic
networks enable localized parameterizations (Park and Sandberg, 1991) in the sense that
each RBF node in the network and its parameters are related to the approximation performance on a particular sub-region of the input space only. This would be a useful feature in
updating only the Q values of the observed state/action pairs along the SARSA iteration,
without modifYing the values of irrelevant pairs.
In the approximation scheme proposed here, the finite state space augmented by the
action space (1t x S x £) is first partitioned into'" nonempty partitions and then the representative state for each sub-region is determined. Such a partitioning could be achieved
effectively by a clustering procedure, such as the k-means algorithm (Bishop, 1995). Then
each of these representative states is assigned as the center of a Gaussian RBF node. The
widths of the RBF nodes are fixed. The considered RBF network here has 3 inputs, namely
Xl [k],

x2[k], and ark]. The output layer consists of a single linear unit with the real weight

vector w. The algebraic function implemented by the network is given by
exp (_IICl -Zll~)

2ai

<p

(z) = w

T

(26)
exp ( - IICf-Zii§)
2a 2
f

where Ci and af are the center and the width parameter of the i-th RBF node, respectively.
The output weights are adjusted in compliance with the original Q-update mecha-

39

nism (22):
w* +-- w*

+ v6(1 + e(x[k], ark]))

(27)

where w* is the output weight parameter from the RBF node whose center is closest to the
observed state/action pair (x[k], ark]).

Experimental Results
To perform an experimental evaluation of the proposed method, an artificial group
of200 patients was used. Out of this group, the first 100 were typical for normal responders,
while the remaining 100 were typical for poor responders. For each individual patient, a
trajectory of EPO, TSAT, and HOB was generated over 6 months.

Experiment 1 A normal responder is considered in this experiment. After setting the Qtable and the eligibility matrix to zero and picking a random initial policy, a trajectory of
length 30 was generated using the TS model described in Section IILC. The variance of
TSAT was

O"§AT

= 100. It is important to note that there is no indication about the patient's

membership in the response group other than the first six entries ofEPO, TSAT, and HOB,
so the patient model is absolutely unknown to the learning system.
The SARSA(A) procedure was then applied as described above with A = 0.1, "Y
0.9, and v

=

= 0.99. Following each Q-update along the trajectory, v was multiplied by 0.9.

The state variable

Xl

settled within the 5% band of the target value 11.5 after 5 episodes.

The Euclidean norm of the difference between the actual HOB level and the target value
11.5 for each episode are shown Figure 4. This figure also presents the variability of HOB
level, expressed in terms of standard deviation.
The resulting policy was finally on a normal responder. The amounts of EPO applied according to the policy and the resulting HOB level are shown in Figure 5. The
effectiveness of the policy obtained by SARSA iteration is evident.

Experiment 2 The subject in this experiment was a patient whose HOB level does not
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procedure.
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adequately change in response to the EPO applied. Such a patient is classified as a poor
responder. Experiment 1 was repeated for this patient with the same

(4SAT'

r,

v, and A

values. The difference between the actual HOB level and the target value over 200 episodes
and the HOB variability are shown in Figure 6.
The resulting policy was tested on a poor responder in a similar vein as it was done
for the normal responder. The EPO doses administered to the patient following the policy
and the corresponding HOB levels are shown in Figure 7.
The magnitude of the action sequence a (i.e. amount of EPO) needed to drive the
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Table 1

Simulation Statistics of SARSA Learning

Responders

HGB level

HGB

EPO dose

EPO

(g/dL)

variability

(1,000 U)

variability

Normal

11.45 ± 0.36

0.44 ± 0.12

14.7 ± 4.5

7.6 ± 2.0

Poor

11.42 ± 0.66

0.91 ± 0.27

43.6 ± 5.8

7.5 ± 6.5

HGB level to the target range and to fix it there was expected to be higher than that of a
normal responder. This phenomenon can be verified from Figures 5 and 7 by comparing
the administered EPO amounts.
The results of the two experiments given above show that the original SARSA(A)
algorithm can be used to adjust the drug dose in both types of responders.
Experiment 3 Having established the ability of the proposed method to discover individ-

ual EPO dosing policies, a series 200 simulations over the whole population of artificially
generated normal and poor responders was performed, where the same SARSA parameters
as in Experiments 1 and 2 were used. The results of this simulation are summarized in Table 1. The HGB level and variability (defined as Standard Deviation) are in gldL, whereas
the EPO dose and variability are in 1,000 Units per week. The entries in the table are mean

± standard deviation (computed over 100 individuals within each response group)
The results summarized in Table 1 confirm the findings of the first two experiments.
The mean HGB levels close to 11.5 for both groups, as well as a relatively low HGB variability show that the proposed method consistently generates adequate EPO administration
policies for both types of responders.
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The RBF-based approximation scheme proposed in Section lV.B.l was finally applied to parameterize the Q-table. The first entry of the RBF centers is associated with
the HGB level (Xl) and the second one to the EPO (a). In this simulation, the TSAT state
component was discarded, because the policy entries were mostly independent of the TSAT
variable. The number £ ofRBF nodes was then picked as 91 and their centers were assigned
to the HGB/EPO pairs in 1i x E. Note that neglecting TSAT value in the determination
centers is equivalent to assigning all states with the same HGB and EPO values to the same
point in the input space. (There are
setting). The width parameters

lSI

= 4 such states for each HGB and EPO in this

0'1, ... , 0'91

have been set equal to 0.01 and initial weights

to zero. The RBF-based SARSA algorithm was performed by replacing (22) with (27) to
the individuals considered in Experiments 1 and 2.
The Euclidean norm of the difference between the policies obtained by the original
SARSA (poIQ) and its approximate version (poIRBF) at each episode is shown in Figure 8.
This plot was generated for the normal responder and the poor responder policy exhibited
almost identical convergence. As can be observed, the approximate version of the SARSA
algorithm converges to a policy similar to the one obtained by the tabular algorithm.

Off-policy Learning of Dosing Policy
To demonstrate an off-policy learning tool on the test-bed, the control-oriented ADP
method introduced in Section 2.C.5 is utilized, where gaining experience and improving the
policy are considered as integrated subtasks to be achieved simultaneously. The learning
occurs in the form of immediate improvements (i.e. Q-value updates) reflected to the policy
due to the experience gained by observing the HGB and EPO sequences of an individual
patient. As delineated below, the learning system is particularly responsible for calculating
optimum actions (EPO in 1,000 Unit steps) to be taken at each representative HGB level.
The amount of EPO to be applied is then calculated based on the actual (non-quantized)
HGB level ofthe patient by an RBF network, which interpolates now the drug dosing policy
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from the finite samples produced by the learning system.

Q-Learning System
Unlike the MDP formulation adapted for episodic learning scheme of the preceding
section, the patient dynamics (c.f. Section IILe) is considered as operating on a continuous
state-space, 1t = [9, 15], S = [0,40], £ = [0,60], but the quantities presented to the
learning system are quantized to some finite representative values denoted by

it, t.

The

learning system observes the quantized current state (HGB level) Xl [k], the quantized action
(EPO dose) o'[k], and the quantized successor state xdk

+ 1].

Given this information, the

rewarding mechanism embedded in the learning system evaluates g(xdkJ, xdk + 1]) based
on the immediate contribution of the current state transition toward the control goal. The
finite-valued reward formula given by (19) is used in the considered learning task. The
proposed control scheme is illustrated in Figure 9.
The update equations in this form of Q-Iearning is the same as (21)-(24). The
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x2[k

xI [k+ I]

xI [k]

z-I

Figure 9. Block diagram of the Q-Iearning-based decision process.

action ark] is then related to the current quantized state Xl [k] through the algebraic policy

p( .) :

it

-+

t.

The learning scheme employs a slightly modified version of the greedy

policy (25), namely E-greedy policy defined by

A

Pc (x) =

{argmaxuEE Q (x, a)
an arbitrary element of £

where

Z

, Z>

E

(28)

otherwise

is a random variable distributed uniformly within [0, 1], and E E [0, 1] is a param-

eter of the learning algorithm. Note that the policy updated in this way contributes to the
exploration effort toward the optimal policy in a different way than the dynamic uncertainty
.1:2

does.
The fundamental difference of this learning scheme from the episodic method of

the preceding section is that the policy update is performed immediately after the Q-table
update. Hence, at any given time, there is no prescribed policy in effect, which makes the
learning off-policy.
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RBF Policy Network
Since the resulting policy (28) obtained by the Q(,X) algorithm is valid only for the
quantized states

x E il,

in order to be applicable to the considered patient model, p(.)

needs to be generalized to the cover H by means of an interpolator.
An RBF network with

lill Gaussian RBF nodes centered at the representative states

is proposed in this study. The actual EPO dose to be applied for a given HGB level Xl [k] is
then determined by this policy network as

exp ( - -X![kl-Sl)
-u(29)

exp ( -

Xl

[k1-S l1il )
u

'

where {Si} l~ll' are the representative states, i.e. the elements of the quantized state space

H.
Since the representative states are equally spaced in H, the spreads

(J

of the Gaus-

sian nodes can be picked as

d

(J

=

2'

so that the outputs of all nodes add up to approximately 1 for all points in
is the distance between two consecutive representative HGB levels in

il.

H, where d
This enables

assigning valid degrees of membership to the representative levels, so that the network
gives an acceptable EPO dose in the form of the weighted sum of the actions imposed by
the discrete policy. In this way, the RBF network plays a critical role by implementing the
algebraic policy in the proposed drug dosing scheme.

Experimental Results
To perform an experimental evaluation of the proposed method, an artificial group
of200 patients was created. Out of this group, the first 100 were typical for normal responders, while the remaining 100 were typical for poor responders. As was done in the testing
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of episodic learning, a trajectory of EPa, TSAT, and HGB was generated over 6 months
for each individual patient.
Five years of anemia management was simulated for each patient group using the
following two methods:
• Q-Ieaming with RBF Policy Network
• Anemia Management Protocol (AMP)
Anemia Management Protocol is a numerical implementation of an EPa administration protocol which is currently used at the Division of Nephrology. This last simulation
was performed to establish a gold standard to which the results obtained by Q-leaming can
be compared. It must be pointed out that the AMP uses a mechanism for determination of
EPa dose which is quite different and more involved than the one used in the Q-Ieaming
based scheme. Furthermore, the administration strategy implemented by AMP is fixed a
priori, as opposed to the one used in Q-Ieaming, which evolves in time. The dose selection

procedure, as implemented in AMP, can be shortly described by the following expression:
l!.EPO

[kl

=

F [HGB[k - 1], HGB[k - 2],
HGB[k - 3], EPO[k - 1ll

This is a higher order dynamic system, as opposed to a simple algebraic policy representation in ADP.
To apply Q-learning, the state (HGB) was quantized into 5 equally sized intervals
with medians at: 9.5, 10.5, 11.5, 12.5, 13.5 g/dL. These four values constituted the finite
set

it explained above.

The finite action set used by the learning system was set as

£=

{O, 5, 10, ... , 60}. Due to clinical constraints, the action values in E were also rounded
to the nearest integer. 6
61,000 EPO Units is the lowest dose increment currently used.
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In each simulation, the treatment was started at the seventh month. The Q-table was
initialized using a best guess method such that the most viable policy was used in the first
step. The best guess policy used in the simulations was as follows:
HGB (g/dL)

9.5

10.5

11.5

12.5

13.5

EPO (1,000 U.) 60
30
15
5
0
When a new patient comes in, they cannot be classified immediately to a response
group. This information is obtained as the treatment progresses. Consequently, using one
sound and common initial policy and tailoring it for the individual patient during treatment is a viable solution. Thus, the same initial policy was used for both response groups.
Furthermore, all updates to the policy entries at the extreme states 9.5 and 13.5 were inhibited. The motivation underlying this decision is that when HGB reaches a dangerously
low level, the maximum EPO dose 60 is the only feasible action. On the other hand, when
HGB level is too high, EPO should be withheld. These extreme states are undesirable and
it is expected that the system avoids them.
Due to the nature of the problem, the policy exploration was limited to time instances when the system was visiting the target state. In other words,
when 11.0 :::;

Xl :::;

E

is nonzero only

12.0. In this case, the exploration probed how decreasing EPO affects

the patient's response. Such an exploration aims at minimizing the patient exposition to the
drug, as well as the total EPO administered.
In the simulation involving the Q-leaming procedure, A was 0.1, the diminishing
learning rate was
was

E

1I

= 11k, the discount factor was "( = 0.9, and the exploration parameter

= 0.3 when the system encountered the target states and

spreads of the RBF nodes were picked as

(T

E

= 0, otherwise. The

= 0.5.

Figures 10 and 11 show the progress of anemia management for a selected representative normal responder. The top plots in each figure depict the HGB trajectory obtained
as a result of administering EPO as shown in the plots second from the top. As an indicator
of convergence of the Q-leaming process, the third plot from the top of Fig. 10 presents
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Figure 10. HGB level (top), EPO dose (second from top), the magnitude ofthe Q-table updates (third from the top), and policy evolution (bottom) for an individual normal responder
as performed by Q-Ieaming with RBF Policy Network.
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Figure 11. HGB level (top) and EPO dose (bottom) for an individual normal responder as
performed by AMP.

the maximum norm of the deviation in the Q-table along the treatment. The bottom plot
in Figure 10 shows the policy evolution. Each curve in the policy plot represents an action for the corresponding state as marked to the right of the plot. By analyzing the HGB
trajectories, it can be concluded that Q-Ieaming achieves the therapeutic goal.
This observation is also confirmed in Tables 2 and 3, where the statistics ofthe simulation are presented in terms of the mean value and the 95% confidence interval calculated
over 100 patients for the following outcome measures:
• mean HGB level over the treatment period,
• standard deviation ofHGB over the treatment period,
• total EPO used during the treatment.
The simulation statistics presented in these tables for normal responders show no significant
clinical differences in terms of quality of anemia management between the two methods.
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Figure 12. HOB level (top), EPO dose (second from top), the magnitude of the Q-table
updates (third from the top), and policy evolution (bottom) for an individual poor responder
as performed by Q-learning with RBF Policy Network.
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Figure 13. HGB level (top) and EPO dose (middle) for an individual poor responder as
performed by AMP.

Figures 12 to 13 show the progress of anemia management for a selected representative poor responder. The most profound difference between the HOB trajectory of a poor
responder and that of a normal one is the time to get to the target range. It takes an average
of 2 months for the HGB to find the target range for a normal responder. For the poor
responder, this period takes from 8 to 18 months. It can be observed that the Q-learning
takes longer to get the HGB level of a poor responder to the target range, compared to the
AMP. This phenomenon can be attributed to the policy update occurring at the beginning
of the therapy. Evidently, the initial action for HOB

= 10.5, namely 30, 000 Units of EPa

administration, is not aggressive enough for a poor responder and causes a drop in HGB.
As mentioned above, HOB below target is an undesired behavior, thus such an action receives a relatively low reward (or punishment) so that a different action is selected in the
next step, based on the Q-table. This process contributes to increasing the time required to
reach the target HOB range. Consequently, the AMP, as a prescribed policy, works faster
for a poor responder, than Q-Iearning, which learns the policy on-the-fly. Nevertheless,
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Table 2

Simulation Statistics for Q-Ieaming

-Response
Normal

Poor

11.59

11.16

(11.12, 12.04)

(10.76,11.55)

HGB

0.29

0.74

Variability

(0.15,0.42)

(0.52,0.95)

Total EPO

589.29

1145.25

(1,000 U)

(344.56,834.02)

(926.61,1363.88)

Group

HGB Level

statistics presented in Tables 2 and 3 for poor responders show that the policy obtained by
Q-Ieaming and AMP achieve a comparable outcome.
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Table 3

Simulation Statistics for AMP

Response
Nonnal

Poor

11.66

11.51

(11.56,11.78)

(11.35,11.67)

HGB

0.32

0.67

Variability

(0.22,0.41)

(0.49,0.84)

Total EPa

610.57

1075.39

(1,000 U)

(356.91,864.23)

(942.50, 1208.28)

Group

HGB Level
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CHAPTER V
GOAL-ORIENTED LEARNING DRIVEN BY CLINICAL KNOWLEDGE

This chapter presents an extension to the Q-Iearning method demonstrated in the
preceding chapter. An alternative Q-value update scheme is proposed here that is based
on a critical prior knowledge about the dose-response characteristic: For all patients, it is
known that the dose-response curve of HGB vs. EPO is monotonically non-increasing.
For example, if a patient's response is evaluated as insufficient for a particular dose at
a particular state, then the physician knows that the optimal dose for that state should
definitely be higher than the administered one. Consequently, there is no need to explore
the benefit of lower doses for that state in future decision stages of treatment.
The conventional Q-Ieaming algorithm does not possess any mechanism to utilize
this type of prior information in learning. Hence, this learning method may lead to suboptimal HGB levels for some patient populations (especially those with decreased EPOresponse). Therefore, an additional mechanism is suggested here to be incorporated in the
original Q-Iearning algorithm so that the information about monotonically increasing character of the HGB vs. EPO curve can be incorporated in the update procedure. It is shown
in the sequel that such a modification will make the EPO dosing faster and, thus, more
efficient.
This study suggests a novel mechanism to perform group updates in Q-table, which
is now considered as a time-invariant but a nonlinear function of the state/action pair encountered. The group of state/action pairs to be updated for each state transition is defined
a priori, with prior knowledge about the problem. Such an aid to the learning process is
categorized as an advice in reinforcement learning theory.
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Use of Advice in Reinforcement Learning
The idea of propagating the experience gained by the most recently-encountered
state/action pair toward the value updates of other pairs is utilized in the general Q('x} algorithm (Watkins and Dayan, 1992). The eligibility trace (Sutton and Barto, 1998) constitutes
an efficient mechanism to implement this learning scheme. Eligibility of a state/action pair

e(x, a) has been defined below eq. (24) as a temporal variable, which attains its maximum
of 1 as soon as (x, a) is encountered in the simulation and vanishes geometrically by the
predefined constant rate ,X E [0,1] along further observations. The value updates of all
state/action pairs are then performed in parallel upon each information gain, but weighted
by their corresponding eligibility.
Eligibility trace performs specific time-varying abstraction temporal difference iteration. It has an accelerating effect on the convergence of the Q-table, since it gives rise
to the update of multiple entries upon the observation of a single state transition. Given the
fact that many real-life problems come indeed with a set of prior information or hints about
their solution, there may be other forms of abstractions as well, and these may aid in the
speed and accuracy of the learning process.

State Abstraction
The earliest work in reinforcement learning literature that utilized region-based updates to evaluate states exactly appears as (Yee et aI., 1990). The definition of regions in
this work were based on concepts organized as a hierarchy to classify the states efficiently.
This hierarchy is optimized by an explanation-based method to yield large, useful regions.
Dietterich and Flann (Dietterich and Flann, 1997) proposed optimal state abstraction routines as components embedded in their value iteration algorithms for planning in
both deterministic and stochastic domains. These methods assume perfect knowledge about
the environment and create adaptively regions of states to be evaluated by Bellman back-
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ups. The inverse approach to the decision sequence and reflecting backups to value table
only upon detecting an improvement in the processed state's value are both inherent features of conventional dynamic programming, e.g. all-pairs shortest path algorithm (Baase
and van Gelder, 1999). These methods were demonstrated on a grid maze (i.e. 2D state
representation) and the regions were rectangular. Experiments verified the expectation that
regional backups accelerate learning.
An attempt to generalize Bellman backups to handle relational logic operators was
made recently in (Kersting et aI., 2004). In particular, this work defines abstract versions
of the components of conventional reinforcement learning by means oflogical queries and
then derives a Bellman operator to evolve these rules to express efficiently the pre-image
of an action that gives rise to a particular state.
These works aim at accelerating learning by making use of some sort of a built-in
procedure to maximize the regions to be updated. However, they allow no manipulation
from the exterior in forming these regions, which are presumably optimally large under
some assumptions on the domain.
From the point of view of this work, such views to state abstraction tend to relate to
hierarchical methods of reinforcement learning eventually, as they draw generalizations on
the state space in unsupervised ways.

Other Forms of Advice
Guiding reinforcement learning with external knowledge has been a major issue for
over a decade. Many researchers have adopted the term advice to name this knowledge
provided/imposed by an external source. Two natural problems arising in dealing with
advice are how to represent it and where to incorporate it in the learning system.
Maclin and Shavlik touched these problems (arguably the former one more than
the latter) in (Maclin and Shavlik, 1996). They actually proposed a reinforcement learning
system, called RATLE, which requests advice from an external observer and assimilates
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the provided information in its internal connectionist structure. In a parallel direction, an
actor/critic learning scheme augmented with an explicit supervisor is presented in (Rosenstein and Barto, 2004). This study addresses the issue of combining supervisor knowledge
with reinforcement signal in an optimal way. These two works present and delineate very
sound scenarios of utilizing advice, which is provided on-the-fly, not a priori.
The works (Ng et al., 1999) and (Wiewiora et al., 2003) propose a computational
method to utilize prior knowledge in Q-Iearning. This is achieved by adding a static and
real-valued potentialfunction of the encountered state/action pair to the right-hand side of
the conventional Q-value iteration. Ng et. al. enlighten in (Wiewiora et al., 2003) the mild
conditions under which this modification does not alter the optimal policy so that the effect
of.potential function is limited to injecting prior knowledge. The latter work generalizes
the potential function to accommodate state transitions, i.e. the 4-tuple (s, a, s', a'), rather
than state/action pairs.
Using potential function is an elegant way of guiding the search of useful actions
with prior knowledge. Employing a fixed value representing prior knowledge in the recursion is a significant extension of setting an initial Q-Iandscape, which can convey the prior
knowledge only temporarily. However, introducing a bias to the iteration as suggested by
this function still necessitates a careful fine-tuning of the iteration parameters, because it
involves the magnitude of Q-updates.

Suggested Abstraction Scheme
This study suggests a predefined partition of state/action space into groups such
that the experience gained by an instance (in the form of state transition

Xk

~

Xk+l

and

corresponding reward) routes the value updates of all elements in the group. Note that it is
actually the form of partitioning of the state/action pairs that represents the prior knowledge
about the problem.
The following example demonstrates the basic idea underlying the suggested state

61

abstraction scheme, which is customizes next for the anemia management problem.

An Example
Consider Markov decision process with finite state and action spaces

S and A,

but with incomplete transition information, andQ-Iearning will be applied to discover the
optimal policy.
Suppose also that S and A are both partially ordered sets and that it is known in
advance that the policy p(.) : S

---+

A governing this process optimally is non-increasing.

This information inherent in the problem implies that, if the action part of an encountered
state/action pair (x*, a*) is evaluated as being unfavorable because of its insufficiency with
respect to the control objective in effect at some point, then the action portions of all pairs
Q(x*, a*)

=

{(x*, a), a E

A : a < a*} could be classified in this way. It is then reason-

able to apply the value iteration to all members ofQ(x*, a*) in parallel with the one for the
individual pair (x*, a*), resulting in decrements in all their values by amounts determined
by the temporal difference iteration. Excluding the exploration mechanism from the discussion, such a group update would reduce the chance of actions a < a* being selected in
future visits to x* (as it is already known -due to the prior knowledge- that those actions
would really be non-beneficial).

State Abstraction Due to Monotonicity
The particular information utilized in the drug dosing problem is that any admissible
drug dosing policy exploits a monotonically non-decreasing relationship between the EPO
dose and the HGB level. This fact validates routing the Q-value updates upon the state
transition Xk

--t

• If 11.5 >

Xk+l

Xk

due to the action

2:

Xk+l

or

Xk

ak

in this way:

= 11.5 >

Xk+},

then add the temporal difference, i.e.

the second term on the right-hand side (16), not only to
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Q(Xk, ak)

but also to all

{Q(x,a): x < xk,a < ad
• Else, if Xk+l 2:-

Xk

> 11.5 or Xk+l >

Xk

= 11.5, then add the temporal difference,

i.e. the second term on the right-hand side (16), not only to Q(Xk, ak) but also to all

{Q(Xb a ): X> Xk,a > ad
• Else, perform the basic Q-update (16) on Q(Xk, ak) only.
Note that the new update scheme punishes a group of state/action pairs whenever
the system exploits an undesired state transition so that the group of actions, which are
certainly unfavorable in the light of the monotonicity information. As a result, such actions
are less likely to be taken in further decision instances, so the learning speed is expected to
improve with the proposed modification.

Experimental Evaluation
The proposed extension was evaulated using an experimental setup similar to the
ones used in Section ry.B. An artificial population of 100 normal responders and 100 poor
responders was created first. For each artificial patient, a set of four initial HOB values
was generated based on the statistics from the above mentioned patient data from 186
individuals. The considered drug dosing mechanism was the one used in Section IY.B,
i.e. the discrete-time control system in Figure 9. The difference from the plain Q-Ieaming
method here is the suggested abstraction scheme developed above.
In the first set of simulations, plain Q-Iearning, i.e. the one without group Qupdates, was applied. Subsequently, the simulations were repeated using the proposed
extended Q-Iearning algorithm that includes group updates using the same experimental
conditions. The evaluation process was completed by simulating the anemia treatment
with a numerical implementation of the Anemia Management Protocol.
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Figure 14. HGB level and EPO dose for an individual normal responder as performed by
plain Q-Ieaming.

Results on Individuals
Figures 14 and 15 show examples of a simulated anemia treatment performed by
the plain Q-Ieaming for a representative normal and poor responder, respectively. These
figures, similar to the ones in Figures 10 and 12, demonstrate that the standard Q-Ieaming
exhibits a tendency to maintain the HGB level close to the upper bound of the target range
in normal responders and close to the lower bound of the target range in poor responders.
Figures 16 and 17 show examples of a simulated anemia treatment performed by
the extended Q-Ieaming method with group updates for a representative normal and poor
responder, respectively. These figures show that the addition of group updates allows for
much better control of HGB level. For both, normal and poor responder, the HGB level is
now much closer to the median of the target range. Hence, one would expect this method
to be more effective than the classical Q-Ieaming in a real clinical environment.

64

14~----------~------------~

____________

~

____________

~

__________

~

12 ""."."""""".""."""".".""."."""""."""".".,,.,,""",,.,,"",,.,,"."." ........................................................ "."".""""."."""""".""""."".,,"""""""""""""",,.,,,,.

'ei

.~

11 """""""""".""""""."",,.,,",,"""""",,..

......................... , ... ,.... , ..

"."""",,.,,""

.,.... ," ....... ... ,...... ", .. ,........ ,.... ,, .... ,.
"""

'" 10
:f

~~~--------~-------------*10------------~1~'------------~20------------~ZS

7Ur------------,------------~------------,-------------~----------_.

~~J------------~------------*10------------~1~5------------*20~----------~20
months
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Figure 18. HGB level and EPa dose for an individual normal responder as performed by
AMP.

Finally, Figures 18 and 19 show examples of a simulated anemia treatment performed by the numerically implemented Anemia Management Protocol. The most striking
phenomenon that can be observed in these figures is the HGB level fluctuation within the
target range. This fluctuation occurs for both types of responders. This observation in the
simulated environment is consistent with actual data from the clinical environment.

Statistical Results
Tables 4 and 5 provide a quantitative comparison between the three simulated methods. The results are reported as means and 95% Confidence Intervals. Comparing the
mean HGB levels of normal responders between the three methods, one can observe that

Q-leaming has a tendency to overshoot the HGB level, whereas Q-leaming with group updates and the Anemia Management Protocol are capable of driving the HGB level to the
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Figure 19. HOB level and EPa dose for an individual poor responder as perfonned by
AMP.

target range. Comparing the standard deviations of HOB levels for nonnal responders between the three methods, one can observe that both Q-Iearning methods provide for more
stable HOB control than the Anemia Management Protocol. Due to the inability of Qlearning to maintain the HOB level within the target range, the third criterion (number of
times HOB out of target range) has a much larger value for this method, compared to the
other two. The amounts of administered EPa are not significantly different between the
three methods.
Comparing the mean HOB levels of poor responders between the three methods,
one can observe that all three methods are capable of driving the HOB level to the target
range. Comparison between the standard deviations of HOB levels reveals that, similarly
as in the case of nonnal responders, Q-Ieaming methods provide more stable HOB control
than the Anemia Management Protocol. In tenns of the number oftimes the HOB level was
out of target range, Q-Iearning with group updates outperfonns the other two competitors.
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Table 4

Statistical Comparison of Anemia Management Methods on Normal Responders

Treatment

Plain

Q-leaming

Method

Q-Ieaming

Group Update

MeanHGB

12.21

11.77

11.75

(g/dL)

(11.77,12.64)

(11.51,12.02)

(11.47,12.02)

StdDev HGB

0.16

0.25

0.50

(g/dL)

(0.06,0.26)

(0.09,0.40)

(0.30,0.70)

Total EPO

286.3

227.8

223.2

(1,000 U)

(200.2,372.5)

(122.3,333.3)

(116.9,329.6)

AMP

Table 5

Statistical Comparison of Anemia Management Methods on Poor Responders

Treatment

Plain

Q-Ieaming

Method

Q-learning

Group Update

MeanHGB

11.44

11.46

11.56

(g/dL)

(10.69,11.91)

(11.18,11.73)

(11.34,11.77)

StdDevHGB

0.26

0.26

0.58

(g/dL)

(0.14,0.37)

(0.12,0.39)

(0.28,0.87)

Total EPO

468.1

469.7

474.9

(1,000 U)

(351.2,585.1)

(334.3,605.3)

(351.2,585.1)
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AMP

The amounts of administered EPO are again not significantly different between the three
methods.
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CHAPTER VI
CONCLUSIONS

This study is presumably the first attempt in formulating a medical treatment process as a model-free approximate dynamic programming instance, and casting reinforcement learning methods for solution.
Having chosen the anemia management as the test-bed, the optimal dmg-dosing
policies of individual virtual patients have been retrieved successfully by using two wellknown reinforcement learning methods SARSA and Q-Iearning. To achieve the control
task using these methods a particular patient model is not required. The methods process
only simulated trajectories obtained from patients. For the purpose of generating these
sample trajectories, a Takagi-Sugeno fuzzy model of an anemia patient has been used in
the simulative treatment.
On-policy temporal difference procedure SARSA has been employed first to extract the optimal drug dosing policies from sample trajectories generated by the patient.
The results show that the episodic SARSA procedure generates adequate dosing strategies
for representative individuals from two different response groups, namely normal and poor
responders. Statistics derived over repeated simulations have confirmed that the obtained
results were consistent with the clinical goals. To facilitate compact parametric representation of the Q-table, the use of an R13F network as an approximator has also been explored.
Initial results showed that it is possible to obtain a convergent RBF approximator for the
Q-table.
Implementation of plain Q-learning with RBF network for policy interpolation has
also been demonstrated. Experimental evaluation has allowed for comparing this method
against the Anemia Management Protocol, regarded here as the gold standard. Statistical
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and clinical analysis of the test results have showed that Q-Iearning is actually capable of
performing adequate anemia treatment in real time, comparable to the Anemia Management Protocol.
Finally, as an extension to the suggested reinforcement learning methods, a novel
state-abstraction mechanism has been proposed and tested experimentally. The suggested
approach has incorporated a useful clinical knowledge, namely the monotonicity of doseresponse characteristic, into the simulative solution process. This constitutes a typical illustration of how problem-specific hints could aid substantially in the solution. The benefit
gained by this addition has revealed itself as a significant improvement in the learning time,
as simulated in the experiments.
Results of this study obtained using artificial patients require elaborate inspections
and many clinical constraints taken into account before they become clinically meaningful
in practice. Such a medical

orient~:d

extension is necessary as it would obviously yield a

fair assessment of the practical value of this research effort.
As a final word, the author would like to stress his viewpoint that neither modelfree nor model-based approaches alone can be successful enough in simulating and improving medical treatment processes, such as anemia management. Therefore, although
inaccuracies of patient models in many medical applications were leading the motivations
of this study, the approaches

pres~:nted

here could be utilized best in collaboration with

mainstream biomedical approaches that focus on modeling patients. A useful decision
mechanism could then be constructed from their constructive trade-off. As an immediate
application of this approach, a hybrid method weighting the decisions from model-free
and model-based decision makers is suggested in (Gaweda et al., 2006b), where weights
assigned to their advices depend on the inaccuracy of the patient model along treatment.
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